Schedule 13G filing

ARK Investment Management LLC disclosed a 5.2% stake in 10x Genomics, Inc. (TXG)

Schedule 13G · Filed Oct 7, 2026

ARK Investment Management LLC reported owning 5.2% of 10x Genomics, Inc. (TXG) (6,272,998 shares) in a Schedule 13G filed Oct 7, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

10x Genomics, Inc.

Stake

5.2% stake

More TXG insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.